NL-OMON41273
Completed
Not Applicable
Serial hybrid atrial fibrillation ablation - SHAFT
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Medisch Spectrum Twente
- Enrollment
- 80
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •All patients screened are accepted for pulmonary vein isolation according to the current guidelines.
- •1\) candidates for enrolment should have long standing persistent or persistent AF as defined in the guidelines for which they received at least one cardioversion with EHRA class \* II
- •2\) Furthermore, on echocardiogram left atrial size needs to be more than \>46 mm on long axis or \>35 cc/m2\.
Exclusion Criteria
- •1\) Significant coronary artery disease has to be excluded as a trigger for AF by means of cardiac CT, if necessary a coronary angiogram will be performed.
- •2\) Previous pulmonary vein isolation (epicardial or endocardial) or cardiac surgery. 3\) Significant valvular disease present on echo (mitral or aortic valve regurgitation above grade 2, moderate to severe mitral or aortic stenosis). 4\) Concomitant cardiac surgery needed 5\) left ventricular ejection fraction \<40% 6\) hypertrophic (obstructive) cardiomyopathy or dilated cardiomyopathy defined as an ejection fraction \< 40% 7\) active infection or sepsis 8\) pregnancy 9\) myocardial infarction within the previous 3 months 10\) AF secondary to electrolyte imbalance, thyroid disease, other reversible or noncardiovascular causes for AF 11\) known sensitivity to heparin or warfarin 12\) life expectancy of \<12 months 13\) pleural adhesions 14\) prior thoracotomy 15\) patients on dialysis
Investigators
Similar Trials
Completed
Not Applicable
BioMonitor III: Validation of the Atrial fibrillation Detecting algorithm in patients undergoing pulmonary vein isolatioAtrial fibrillationirregular heart rhythm10007521NL-OMON48234Erasmus MC, Universitair Medisch Centrum Rotterdam30
Not yet recruiting
Not Applicable
BioMonitor III: Validation of the Atrial fibrillation Detecting algorithm in patients undergoing pulmonary vein isolatioParoxysmal and persistent atrial fibrillationNL-OMON23516Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands30
Active, not recruiting
Phase 1
Commercial study conducted to determine the most adequate supplementation of vitamin D in patients showing vitamin D deficiencyPatients of 18 years of age or more with vitamin D deficiencyMedDRA version: 14.1Level: PTClassification code 10047626Term: Vitamin D deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2012-004917-14-BEABORATOIRES SMB S.A
Recruiting
Not Applicable
The TAPS Trial;Fetoscopic Laser Surgery for Twin Anemia Polycythemia Sequence: a multicenter open label randomized controlled trialNL-OMON46380Verloskunde10
Completed
Phase 2
A Phase 2, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects with Hypertension, in the Absence of Antihypertensive MedicationsHigh blood pressurehypertension10057166NL-OMON54821Ablative Solutions Inc50